Skip to main content
Clinical Trials/NL-OMON24504
NL-OMON24504
Recruiting
N/A

Health-Related Quality of Life Assessment And Communication During 48 Weeks of Treatment of Moderate to Severe Psoriasis.

Stichting AquamarijnMeibergdreef 91105 AZ AMSTERDAM ZO0 sites200 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Keywords:Psoriasis, Health-Related Quality of Life, Etanercept.doctor-patient communication, psoriasis patients
Sponsor
Stichting AquamarijnMeibergdreef 91105 AZ AMSTERDAM ZO
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Stichting AquamarijnMeibergdreef 91105 AZ AMSTERDAM ZO

Eligibility Criteria

Inclusion Criteria

  • 1\. Eighteen years of age or older at time of consent.
  • 2\. Established diagnosis of plaque psoriasis.

Exclusion Criteria

  • 1\. Patients of childbearing potential who are not using or willing to use adequate anti\-conceptive measures.
  • 2\. Contraindications for the use of etanercept: sepsis or risk of sepsis, including local infections.

Outcomes

Primary Outcomes

Not specified

Similar Trials